Authors: Gray, A Clarke, P Raikou, M Adler, A Stevens, R Neil, A Cull, C Stratton, I Holman, R

Citation: A. Gray et al., An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54), DIABET MED, 18(6), 2001, pp. 438-444

Authors: Clarke, P Gray, A Adler, A Stevens, R Raikou, M Cull, C Stratton, I Holman, R

Citation: P. Clarke et al., Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51), DIABETOLOG, 44(3), 2001, pp. 298-304

Authors: Gray, A Raikou, M McGuire, A Fenn, P Stevens, R Cull, C Stratton, I Adler, A Holman, R Turner, R

Citation: A. Gray et al., Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41), BR MED J, 320(7246), 2000, pp. 1373-1378

Authors: Schultz, CJ Konopelska-Bahu, T Dalton, RN Carroll, TA Stratton, I Gale, EAM Neil, A Dunger, DB

Citation: Cj. Schultz et al., Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study, DIABET CARE, 22(3), 1999, pp. 495-502

Authors: Horton, V Stratton, I Bottazzo, GF Shattock, M Mackay, I Zimmet, P Manley, S Holman, R Turner, R

Citation: V. Horton et al., Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43), DIABETOLOG, 42(5), 1999, pp. 608-616

Authors: Turner, RC Holman, R Stratton, I

Citation: Rc. Turner et al., The UK Prospective Diabetes Study - Reply, LANCET, 352(9144), 1998, pp. 1934-1934